CS-7017 in Combination With Carboplatin/Paclitaxel in Subjects With Stage IIIb/IV Non-small Cell Lung Cancer (NSCLC)

NCT01199055 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma, Non-Small-Cell Lung

Interventions

DRUG: CS-7017
DRUG: Carboplatin
DRUG: Paclitaxel

Sponsor

Daiichi Sankyo Co., Ltd.

Collaborators

[object Object]